Impact of targeting deviations on outcome in medulloblastoma: Study of the French society of pediatric oncology (SFOP)

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 2, 1999, Pages 435-439

  Carrie, C ^a   Hoffstetter, S ^b   Gomez, F ^a   Moncho, V ^c   Doz, F ^d   Alapetite, C ^d   Murraciole, X ^e   Maire, J P ^f   Benhassel, M ^g   Chapet, S ^h   Quetin, P ⁱ   Kolodie, H ^j   Lagrange, J L ^k   Cuillere, J C ^l   Habrand, J L ^m  

^a CENTRE LÉON BÉRARD   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d INSTITUT CURIE   (France)

^e TIMONE HOSPITAL   (France)

^f HÔPITAL SAINT ANDRÉ   (France)

^g CENTRE EUGÈNE MARQUIS   (France)

^h CHU BRETONNEAU   (France)

ⁱ CENTRE PAUL STRAUSS   (France)

^j HÔPITAL MICHALLON   (France)

^k CENTRE ANTOINE LACASSAGNE   (France)

^l CENTRE RENÉ GAUDUCHEAU   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

Craniospinal irradiation; Medulloblastoma; Quality Assurance

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON BEAM; HUMAN; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; POSTERIOR FOSSA; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENCE RISK; SPINAL CORD; TEMPORAL LOBE;

ADOLESCENT; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FRANCE; HUMANS; MEDICAL ONCOLOGY; MEDULLOBLASTOMA; PROSPECTIVE STUDIES; QUALITY CONTROL; RADIOTHERAPY; SOCIETIES, MEDICAL;

EID: 0032842530     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00200-X     Document Type: Article

References (13)

1. Berry M.P., Jenkin R.D.T., Keen C.W. Radiation therapy for medulloblastoma A 21 years review . Neurosurg. 55:1981;43-51.
2. Cutler E.C., Sosman M.C., Vaughan W.W. Place of radiation in treatment of cerebellar medulloblastoma Report of 20 cases . Am J Roentgenol Radium Ther. 35:1936;429-453.
3. Evans A.E., Kramer S., Chang C., et al. The treatment of medulloblastoma Results of a randomized trial of radiation therapy with and without CCNU-vincristine and prednisone . Neurosurg. 72:1990;572-582.
4. Hershatter B.V., Halperin E.C., Cox E.B., et al. Medulloblastoma The Duke University Medical Center experience . Int J Radiat Oncol Biol Phys. 12:1986;1771-1777.
5. Tait D.M., Thornton J.H., Bloom H.J.G., et al. Adjuvant chemotherapy for medulloblastoma The first multicentric control trial of the International Society of Pediatric Oncology (SIOP) . Eur J Cancer. 26:1990;464-469.
6. Carrie C., Alapetite C., Mere P., et al. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study The contribution of radiotherapy technique to tumor relapse . Radiol Oncol. 24:1992;77-81.
7. Donnal J., Halperin E.C., Friedman H.S., et al. Subfrontal recurrence of medulloblastoma. Am J Neuroradiol. 13:1992;1617-1618.
8. Uozumi A., Yamaura A., Makino H., et al. A newly designated radiation part for medulloblastoma to prevent metastasis to the cribriform plate region. Childs Nerv Syst. 6:1990;451-455.
9. Grabenbauer G.G., Beck J.D., Erhordt J., et al. Postoperative radiotherapy of medulloblastoma Impact of radiation quality on treatment outcome . Am J Clin Oncol. 19:1996;73-77.
10. Halberg F.E., Wara W.M., Fippin L.F., et al. Low dose craniospinal radiation therapy for medulloblastoma. Int J Radiol Oncol Biol Phys. 20:1991;651-652.
11. Drayer J.A., Marks L.B., Bentel G., et al. Defining the superior border of posterior fossa radiation treatment fields. Int J Radiol Oncol Biol Phys. 41:1998;625-629.
12. Liu M, Carrie C, Parker W; et al. A simple and accurate method of generating customized blocks for whole brain fields used in the treatment of medulloblastoma. Clin Invest Med 1998;(Suppl.)S87.
13. Dunst J., Jurgens H., Sauer R., et al. Radiation therapy in Ewing's sarcoma An update of the CESS 86 trial . Int J Radiol Oncol Biol Phys. 32:1995;919-930.